BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32811432)

  • 1. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
    Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
    PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 12. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
    Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
    [No Abstract]   [Full Text] [Related]  

  • 13. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.
    Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
    Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
    Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
    Xiao W; Du LY; Mao B; Miao TW; Fu JJ
    BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.